Hapbee’s (HAPB) TV Series, to Air Over Syndicated Television Networks.

New to The Street TV and Hapbee Technologies, Inc. Sign Contract for 12 Part TV Series Across Syndicated Television Networks

2020 Biotech Portfolio Soars 55%, We’re Amazed. Next Up: The Coming Gold Rush.

1. Yep, We Are Absolutely Amazed At The Biotech Stock Review's 2020 Watch List Performance – Especially In The Light Of...
hapbee

Adding Hapbee Tech (HAPB, HAPBF) $0.34 to Biotech Six Pack Watch List.

UPDATE ON BIOTECH SIX PACK, SIX STOCKS WE EXPECT TO DOUBLE. While the Biotech Stock Review was launched...
HAPBEE

Hapbee (HAPB): The Netflix of Feelings

After 15 years, $70 million spent on R&D, and 350,000+ hours of testing, this "Netflix of Feelings" wearable technology is finally...
Biotech Stock Review,

Premier Health (PHGRF) Announces Definitive Agreement to Acquire Livecare.

Livecare is an established leader in the Canadian digital health spaceHave provided over 27,000 telemedicine visitsService over 500 independent active health practitioner...

Telehealth DTC Startup Ro is now Offering Coronavirus Assessments (ModernRetail).

Ro — a DTC telehealth company for everything from erectile dysfunction to helping quit smoking — has a new service aimed at...

How CoronaVirus Accelerated the Rise of Telemedicine (CNBC). Telehealth.

16 minute video on how hospitals and primary care practices are using it and what it could mean for the future of...
GBT Technologies, GTBC

Adding GBT Technologies (GTCH) to the Watch List.

Massive Potential From California Based Technology Think Tank. Yes, risky - as in...
CB Scientific

Telehealth: CB Scientific (CBSC) Acquires Prevent Health Care International Corp.

CB Scientific, Inc. (CBSC) Announces Completion of Asset Purchase Agreement and Commencement of Its ECG Monitoring Business.

Latest article

Smart for Life (SMFL) Capitulates?

We Are Long Term Bullish on Smart for Life. After a Volatile Post IPO Trading, we may Have Seen the Bottom....

Althira (ATHA) $2.50, is Latest Alzheimer’s Trial Victim. Down 70%

Nearly 100 Alzheimer’s programs have failed in the past decade. Biotech investors should study or at least become...

Novogratz Remains Steadfast on Crypto, Says Wait Until Next Year (Bloomberg)

Great call. This was actually from Late 2018. (Bloomberg) — Billionaire investor Michael Novogratz is resolute when it...